Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
1.290
-0.050 (-3.73%)
At close: May 30, 2025, 4:00 PM
1.320
+0.030 (2.33%)
After-hours: May 30, 2025, 7:45 PM EDT

Tevogen Bio Holdings Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-35.36-13.73-60.48-22.04-15.6
Depreciation & Amortization
0.410.40.380.230.01
Stock-Based Compensation
21.7240.76-4.580.58
Other Operating Activities
1.76-39.4351.648.3210.98
Change in Accounts Payable
-0.551.691.110.35-1.09
Change in Other Net Operating Assets
-0.33-1.69-0.82-0.1-0.16
Operating Cash Flow
-13.14-12-8.17-8.66-5.27
Capital Expenditures
---0.13-0.48-0.11
Investing Cash Flow
---0.13-0.48-0.11
Long-Term Debt Issued
-147.512.5
Net Debt Issued (Repaid)
3147.512.5
Other Financing Activities
-0.23-0.13--
Financing Cash Flow
13.812.233.877.512.5
Net Cash Flow
0.660.23-4.43-1.637.12
Free Cash Flow
-13.14-12-8.3-9.13-5.38
Free Cash Flow Per Share
-0.09-0.08-0.34-0.36-0.21
Levered Free Cash Flow
-0.359.82-3.52-4.11-
Unlevered Free Cash Flow
-0.329.93-2.77-3.53-
Change in Net Working Capital
0.15-2.24-2.51-0.72-
Updated Nov 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q